Home › Compare › TSDOF vs ABBV
TSDOF yields 3.66% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, TSDOF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TSDOF + ABBV for your $10,000?
Tessenderlo Group NV, together with its subsidiaries, engages in the agriculture, valorizing bio-residuals, energy, and industrial solution businesses worldwide. It operates through four segments: Agro, Bio-Valorization, Industrial Solutions, and T-Power. The Agro segment engages in the production, marketing, and trading of crop nutrients, including liquid crop and potassium sulfate fertilizers, as well as crop protection products. This segment offers its specialty fertilizers under the Thio-Sul, KTS, K-Row 23, CaTs, GranuPotasse, SoluPotasse, and K-Leaf brands; agriculture herbicides under the LINEX and VELPAR brand names; SEVIN, an agricultural insecticide; and SECTAGON, an agricultural fumigant. The Bio-Valorization segment produces, sells, and trades in gelatins and collagen peptides, and proteins and fats for food, pharma, health and nutrition, pet food, agriculture, aqua feed, animal feed, energy, biodiesel, oleo-chemistry, and sanitary markets. The Industrial Solutions segment is involved in the production, sale, and trading of plastic pipe systems; water treatment chemicals; and other industrial activities, such as the production and sale of mining and industrial auxiliaries, and delivery of services for the treatment and disposal of produced and flowback water from oil and gas exploration, as well as the recovery of industrial process fluids. The T-Power segment produces electricity through a combined cycle gas turbine of 425 MW capacity. It serves agriculture, food, industry, construction, health, and consumer goods end markets. The company was formerly known as Tessenderlo Chemie nv and changed its name to Tessenderlo Group NV in June 2017. The company was founded in 1919 and is headquartered in Brussels, Belgium. Tessenderlo Group NV is a subsidiary of Verbrugge NV.
Full TSDOF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.